Yet Another Myeloma CAR-T Therapy Makes It Onto EMA’s PRIME
Another investigational Chikungunya vaccine has also entered PRIME
Only two of seven applications for entry into the European Medicines Agency’s priority medicines scheme for getting treatments for unmet medical need to patients faster were successful last month.
